Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Cancer Research|November 4, 2005
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomasXueqing Lun, Wenqing Yang, Tommy Alain, et al.Breast Cancer Research and Treatment|June 19, 2019
Breast leptomeningeal disease: a review of current practices and updates on managementNicholas B Figura, Victoria T Rizk, Avan J Armaghani, et al.Journal of Neuro-Oncology|July 25, 2023
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastasesVaseem M Khatri, Matthew N Mills, Daniel E Oliver, et al.Journal of Neuro-Oncology|April 10, 2008
Toxicity from chemoradiotherapy in older patients with glioblastoma multiformeAngelique E Sijben, John B McIntyre, Gloria B Roldán, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Imaging correlates of molecular signatures in oligodendrogliomasJoseph F Megyesi, Edward Kachur, Donald H Lee, et al.Journal of Neuro-Oncology|December 19, 2014
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastasesKamran A Ahmed, Jessica M Freilich, Sarah Sloot, et al.Neuro-Oncology|March 11, 2016
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastomaAlexandra Pisklakova, Brienne McKenzie, Franz Zemp, et al.Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.Clinical Lung Cancer|May 8, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy AloneMatthew N Mills, Akihiro Uno, Pinxue Li, et al.Pageof 15